Sherbrooke Park Advisers’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,353
Closed -$471K 373
2025
Q3
$471K Buy
6,353
+1,803
+40% +$183K 0.22% 185
2025
Q2
$590K Buy
+4,550
New +$660K 0.26% 132
2023
Q4
Sell
-3,220
Closed -$639K 574
2023
Q3
$639K Buy
+3,220
New +$812K 0.2% 188

Other funds holding INSP

Sherbrooke Park Advisers's INSP Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 6,353 shares — an estimated $471K sold.

Sherbrooke Park Advisers first reported a position in INSP in Q3 2023 and held it in 3 quarters. The position peaked at $639K in Q3 2023. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 6,353 Inspire Medical Systems shares in Q4 2025, an estimated $471K.
  • Sherbrooke Park Advisers first reported a position in Inspire Medical Systems in Q3 2023 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Inspire Medical Systems position peaked at $639K in Q3 2023.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.